3 hours 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been given an average rating of “Moderate Buy” by the nine research firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the st…
X